The Relative Failure of Conventional Oncology *

While conventional oncology has been more successful with the “liquid” cancers (e.g. lymphomas and leukemia), it has over-all failed with regard to the safe and efficient control and reversal of “solid” cancers, which constitute the vast majority of malignancies that affect humans and animals.

 “The overall contribution of curative and adjuvant cytotoxic chemotherapy to 5-year survival in adults was estimated to be 2.3% in Australia and 2.1% in the USA”. Cf. Morgan G1, Ward R, Barton, The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies. M.  Clin Oncol (R Coll Radiol). 2004 Dec;16(8):549-60. (Source) (1) (*)

Resistance to chemotherapy and molecularly targeted therapies with high recurrence rates have been a major hallmark of conventional oncology. (2)

Not only can chemotherapy worsen the tumor’s micro-environment, it can also make the cancer circulating stem cells, which are the engines of metastases, mutate and spread even more.  Radiation has similar effects. (Source)  Likewise with many biopsies and surgeries, they too can significantly contribute to the spreading of  malignancies,  via the cellular adhesion, immune suppression, surgical stress and inflammatory pathways. And to make matters worse, many conventional diagnoses and prognoses have built-in and often  fatal flaws.

All of these “perverse effects” (as sociologists) call them, or “unexpected consequences” (as staticians call them) are logical consequences of the type of medical model that has been put in place.

Good News with Holistic Medicine

On the other hand, with well-designed holistic, immunotherapeutic and metabolic cancer protocols, most cancer patients can expect a  50 to 100 percent survivability success rate, (defined as at least five years of remission), with few if any side effects. (3).

Even better, with Joubert’s HIP protocol, cancer patients can even expect a longer healthy Life than those  patients who have not contracted a cancer diagnosis, provided that these patients have not irreversibly harmed their genetic and vital bodily functions with synthetic drugs, invasive surgeries, processed and junk “foods”, radiation, genetic mutations, toxemia and decades of chronic stress.


While there has been some progress with Conventional Oncology Research and Praxis, (Source) in particular, with conventional immunotherapy for especially melanoma, the Allopathic Model still appears to be structurally flawed. If only because none of the conventional anti-cancer approaches take in consideration the patient’s “placebo-based” abilities, his or her microbiome, toxic load, traumas, lifestyle, immune system and nutritional status.

On the other hand, Holistic Oncology as taught by the ACR Institute never neglects the power of hope and placebo, let alone the patient’s toxic load, microbiome, nutritional & bio-electrical status, traumas, immune system and lifestyle.

Two Distinguished Professors of Medicine & Editors-in-Chief Testify about the serious medical unethical behavior and malfeasance of today’s Mainstream Conventional Medical System

“A lot of what is published is incorrect.” I’m not allowed to say who made this remark because we were asked to observe Chatham House rules. (…) Why the paranoid concern for secrecy and non-attribution? Because this symposium—on the reproducibility and reliability of biomedical research, held at the Wellcome Trust in London last week—touched on one of the most sensitive issues in science today: the idea that something has gone fundamentally wrong with one of our greatest human creations.” (The editor in chief of Lancet, Richard Horton). (Source)

The medical profession is being bought by the pharmaceutical industry, not only in terms of the practice of medicine, but also in terms of teaching and research. The academic institutions of this country are allowing themselves to be the paid agents of the pharmaceutical industry. I think it’s disgraceful.”  Arnold Seymour Relman (1923-2014), Harvard Professor of Medicine and Former Editor-in-Chief of the New England Medical Journal 

Professor Joubert, the ACR Institute director, agrees with these above-mentioned expert-testimonies. Actually, Pr. Joubert knows that the health arena is worse than what Drs Relman and Horton and others describe. Joubert as a former “medmal” (medical malpractice) litigator has accumulated over the years strong evidence that shows an abundance of politically accepted unethical and criminal behavior within the public health and medical spheres.

The right to health is a fundamental part of international law, which is via Article 6 of the Federal Constitution the “Supreme Law of the Land”.  US Constitutional Law confirms this Right. Yet, most of the country’s law-makers who amass massive campaign donations from dubious sources continue to side-step the exigencies that go with this basic right and their political mandate.

To read the dozens of exhibits that confirm conventional medicine’s and conventional oncology’s limitations and unreliability, click here (link reserved to registered viewers)

To learn about Coaching & Training Sessions, click here.

To view the Institute’s Private coaching data on Cancer cells’ Biological Strengths and Weaknesses  Click Here (Password protected)

(*) Sources have been deactivated and are reserved for the registered viewers.


(1). This Study is the result of close to one hundred studies incorporated within this meta-analysis. Other meta-analyses confirm this one, where less than 3 percent of cancer patents make it to five 5 years.  This is true  only when chemo is used as a stand alone. When more holistic techniques accompany chemo, radiation or surgery, the results are a little better. For the liquid cancers, the 5 years rate of survival can reach 40 to 50 percent. But what is usually not stated is that many of these cancers tend to come back after the 5 years mark. And if they do, they are considered to be new cancers.
(2). The mechanisms of resistance to  conventional cytotoxic chemotherapeutics share many features, such as alterations in the drug target, activation of prosurvival pathways and ineffective induction of cell death. (Source). In the end, most advanced cancer patients tend not to survive relapse.
(3). Unless the patient first adopted a harmful conventional treatment and-or is not compliant to the holistic protocol. Given the costs (hundreds of millions to billions of dollars), human RCT (randomized control trials) can’t exist in holistic oncology, if only because most of holistic oncology is lifestyle medicine and this type of medicine is not patentable, nor can it be squeezed into a double blind RCT. On the other hand, there are a few prospective and observational studies that confirm holistic and integrative oncology’s clinical superiority over conventional oncology, See blog.

Screen Shot 2015-04-24 at 5.34.39 PM

Copyright (c) 2019: Advanced Cancer Research Institute, Pr Joubert and agents. All rights reserved. In terms of “fair use”,  the Institute allows the free use of this posted article provided it is not altered, full attribution is included as well as the Institute’s Post URL link. Furthermore, consistent with “fair use” case law,  small sections from the Institute’s posted article can be used as long as the above mentioned attributions are made and as long as the usage purpose is based on furthering education and science. For any other usage reason, written permission is required.
DISCLAIMER. Nothing in this blog-webstie is to be construed as medical or legal advise, including, but not limited to replies, comments and posts, all of which can not be deemed to constitute either a therapist-patient nor an attorney-client relationship.  For additional details about privacy policy & terms of use, please see the Institute’s legal link.
Translate »
error: Content is protected !!